Chemomab Therapeutics (CMMB) Non-cash Items (2020 - 2023)
Chemomab Therapeutics' (CMMB) quarterly Non-cash Items came in at -$1.1 million in Q3 2023, down 140.39% YoY from $2.8 million in Q3 2022, and down 335.74% on a QoQ basis from $484000.0 in Q2 2023.
Chemomab Therapeutics (CMMB) Non-cash Items (2020 - 2023) Analysis & Trends
Chemomab Therapeutics (CMMB) has 4 years of Non-cash Items data on file, last reported at -$1.1 million in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.71 Bn | 130.86 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.60 Bn | 77.60 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.82 Bn | 59.63 Bn | 1.37 Bn |
| 4 | Moderna | 57.92 Bn | 52.79 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.88 Bn | 36.78 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.46 Bn | 28.15 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.96 Bn | 9.57 Bn | 668.28 Mn |
| 8 | Insmed | 27.35 Bn | 26.19 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Chemomab Therapeutics | 13.52 Mn | 3.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -1.14 Mn |
| Sep 30, 2023 | -1.14 Mn |
| Jun 30, 2023 | 484,000.00 |
| Jun 30, 2023 | 484,000.00 |
| Mar 31, 2023 | 1.57 Mn |
| Mar 31, 2023 | 1.57 Mn |
| Sep 30, 2022 | 2.83 Mn |
| Sep 30, 2022 | 2.83 Mn |
| Jun 30, 2022 | 489,000.00 |
| Jun 30, 2022 | 489,000.00 |
| Mar 31, 2022 | 1.39 Mn |
| Mar 31, 2022 | 1.39 Mn |
| Sep 30, 2021 | 388,000.00 |
| Sep 30, 2021 | 388,000.00 |
| Jun 30, 2021 | -2.84 Mn |
| Jun 30, 2021 | -2.84 Mn |
| Mar 31, 2021 | 411,000.00 |
| Mar 31, 2021 | 411,000.00 |
| Sep 30, 2020 | 323,000.00 |
| Sep 30, 2020 | 323,000.00 |